Skeletal fluorosis affecting two or more distinct anatomical sites simultaneously, classified under disorders of bone density and structure.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 12
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M85.19.
Source · Editorial brief grounded in 5 cited references ↓
- Explicitly name each affected anatomical site in the assessment — 'skeletal fluorosis of the spine and bilateral lower extremities' is sufficient; 'multiple sites' alone mirrors the unspecified language and should be avoided without further detail.
- Record the fluoride exposure source (endemic water, industrial exposure, iatrogenic) to support medical necessity and distinguish from metabolic bone disease mimics.
- Document radiographic findings by site: osteosclerosis grade, periosteal reaction, ligament calcification, and any cortical thickening on plain films or CT.
- Note any functional impairment, restricted range of motion, or neurologic compromise from canal narrowing, as these findings support medical necessity for advanced imaging and specialist referral.
- If serum or urinary fluoride levels were obtained, include results in the record to corroborate the diagnosis, particularly when the exposure history is uncertain.
Related CPT procedures
Procedure codes commonly billed with M85.19. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M85.19 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M85.19 when only one site is documented — review the note carefully and assign the site-specific M85.1xx code instead; M85.19 is reserved for genuinely polyostotic involvement.
- Failing to check the Excludes1 list under M85 before coding: polyostotic fibrous dysplasia (Q78.1) and osteopetrosis (Q78.2) can radiographically mimic multi-site fluorosis but are hard-blocked from being coded alongside M85.19.
- Confusing M85.19 (multiple sites) with M85.18 (other site) — 'other site' applies to a single anatomical location not listed in the site-specific subcategories, not to more than one site.
- Omitting a secondary code for the underlying exposure when relevant (e.g., a Z-code for occupational exposure history), which can weaken the clinical narrative and risk-adjustment record.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M85.19 applies when skeletal fluorosis is documented at multiple discrete sites — for example, concurrent involvement of the spine and lower extrembs, or upper and lower limb bones together. Use M85.19 only when the record explicitly identifies more than one affected region; if fluorosis is confined to a single named site, select the corresponding site-specific code within M85.1x (e.g., M85.151/M85.152 for thigh, M85.161/M85.162 for lower leg). If only one site is affected but laterality is unspecified, use M85.10 (unspecified site).
Skeletal fluorosis results from chronic excessive fluoride exposure — historically through endemic high-fluoride groundwater, industrial inhalation, or prolonged high-dose therapeutic fluoride use. Radiographic findings drive the diagnosis: osteosclerosis, periosteal new bone formation, ligament calcification, and cortical thickening are characteristic. The spine, pelvis, and long bones are most commonly involved, which is why multi-site presentation is the clinical norm rather than the exception.
M85.19 maps to MDC 08 (Diseases & Disorders of the Musculoskeletal System & Connective Tissue) under MS-DRG grouping per CMS v37.2. The M85 category carries an Excludes1 note blocking concurrent use with osteogenesis imperfecta (Q78.0), osteopetrosis (Q78.2), osteopoikilosis (Q78.8), and polyostotic fibrous dysplasia (Q78.1) — verify none of these apply before assigning M85.19.
Sibling codes
Other billable codes under M85.1 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When should I use M85.19 instead of a site-specific M85.1 code?
02What is the difference between M85.18 and M85.19?
03Does M85.19 have any Excludes notes I need to check?
04Is imaging required to bill M85.19?
05Which MS-DRG does M85.19 group to?
06Can M85.19 be used as a primary diagnosis for an orthopedic encounter?
07Should I also code the fluoride exposure when using M85.19?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026
- 02CMS MS-DRG v37.2 Definitions Manual — MDC 08, https://www.cms.gov/icd10m/version372-fullcode-cms/fullcode_cms/P0667.html
- 03AAPC Codify — M85.19, https://www.aapc.com/codes/icd-10-codes/M85.19
- 04icd10data.com 2026 — M85.19, https://www.icd10data.com/ICD10CM/Codes/M00-M99/M80-M85/M85-/M85.19
- 05CMS ICD-10-CM Official Guidelines for Coding and Reporting FY2019 (general conventions), https://www.cms.gov/Medicare/Coding/ICD10/Downloads/2019-ICD10-Coding-Guidelines-.pdf
Mira AI Scribe
Mira AI Scribe captures the names of all involved skeletal sites, the documented fluoride exposure source, and key imaging findings (osteosclerosis, periosteal reaction, ligament calcification) from the encounter note. That specificity prevents a drop to the unspecified M85.10 code, closes the Excludes1 conflict risk, and ensures the claim supports medical necessity for multi-site imaging or specialist referral.
See how Mira captures M85.19 documentation